Get the Stockscreener App
1.375
0.36%
0.005
Bionano Genomics Inc stock is traded at $1.375, with a volume of 59,407.
It is up +0.36% in the last 24 hours and down -11.86% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$1.37
Open:
$1.38
24h Volume:
59,407
Relative Volume:
0.23
Market Cap:
$16.19M
Revenue:
$28.74M
Net Income/Loss:
$-31.60M
P/E Ratio:
-0.2706
EPS:
-5.0805
Net Cash Flow:
$-19.30M
1W Performance:
-5.82%
1M Performance:
-11.86%
6M Performance:
+7.42%
1Y Performance:
-34.99%
1-Day Range:
$1.3303
$1.40
1-Week Range:
$1.2903
$1.50
52-Week Range:
$1.00
$2.23
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.375 | 16.19M | 28.74M | -31.60M | -19.30M | -5.0805 |
ISRG
Intuitive Surgical Inc
|
426.28 | 150.60B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
192.66 | 52.48B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
241.63 | 33.98B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.72 | 32.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.63 | 32.14B | 29.14B | 1.07B | 1.05B | 1.1956 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Viking Therapeutics plans $400M stock and conve... - Pluang
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance Singapore
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance UK
Why Is Bionano Genomics (NASDAQ:BNGO) Standing Out as Traders Parse Sector Signals and Macro Pressure? - Kalkine Media
Why Has Bionano Genomics (BNGO) Returned to the Spotlight? - Kalkine Media
Local Coverage Determinations Roundup: ChromaCode, Biofidelity, Biocartis, Bionano Genomics - GenomeWeb
MolDX proposes Medicare coverage for Bionano genome mapping test - Investing.com
MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Canada
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - The Manila Times
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - marketscreener.com
MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Nigeria
Bionano Genomics (NasdaqCM:BNGO) Stock Forecast & Analyst Predictions - Simply Wall Street
Bionano Genomics (BNGO) interim CEO adds 4,000 shares in IRA - Stock Titan
Bionano Laboratories Announces New York State Department of - GlobeNewswire
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo
Bionano Genomics (NASDAQ:BNGO) Shares Turns Active on Today’s Market Trigger - Kalkine Media
Bionano Genomics Inc. Warrant (BNGOW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Peer Comparison – Compare with Others - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bionano Genomics Inc. Warrant (BNGOW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Bionano Genomics Inc. (BNGO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - Value Research
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Barchart.com
Bionano Genomics (NASDAQ: BNGO) interim CEO buys 4,000 shares - Stock Titan
Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest TradingLong-Term Guidance - vinanet.vn
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - qz.com
Bionano Genomics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - AOL.com
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Alex Reid Hastie Net Worth (2026) - GuruFocus
Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan
Gossamer Bio: Q2 Earnings Snapshot - AOL.com
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria
Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha
Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Canada
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Bionano Genomics Q2 Results: Revenue rises 21% to $8.2 million - scanx.trade
Bionano Genomics Q3 Results: Sales guidance ranges $8.200M-$8.600M - scanx.trade
BNGO Looks 21.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings - Quiver Quantitative
How Could Bionano Genomics (NASDAQ:BNGO) Influence Penny Stocks Sentiment? - Kalkine Media
Bionano Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bionano Genomics Inc Stock (BNGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Luderer Albert | Interim Chief Executive |
Aug 21 '26 |
Buy |
1.22 |
4,000 |
4,860 |
4,000 |
0.52%
9.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):